On 2024-05-13, Cocrystal Pharma, Inc. (COCP) announced earnings per share of $-0.39 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-0.54.
The next expected annoucement date for quarterly earnings is 2024-08-12, with an average estimated earnings per share of $-0.50 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-13 | 2024-03-31 | $-0.54 | $-0.39 |
| 2024-03-28 | 2023-12-31 | $-0.57 | $-0.44 |
| 2023-11-13 | 2023-09-30 | $-0.47 | $-0.41 |
| 2023-08-14 | 2023-06-30 | $-0.53 | $-0.50 |
| 2023-05-15 | 2023-03-31 | $-0.59 | $-0.64 |
| 2023-03-29 | 2022-12-31 | $-0.72 | $-0.55 |
| 2022-11-14 | 2022-09-30 | $-0.49 | $-0.70 |
| 2022-08-15 | 2022-06-30 | $-0.48 | $-0.48 |
| 2022-05-11 | 2022-03-31 | $-0.48 | $-0.48 |
| 2022-03-23 | 2021-12-31 | $-0.48 | $-0.48 |
| 2021-11-15 | 2021-09-30 | $-0.48 | $-0.48 |
| 2021-08-16 | 2021-06-30 | $-0.48 | $-0.48 |
| 2021-05-17 | 2021-03-31 | $-0.48 | $-0.48 |
| 2021-03-17 | 2020-12-31 | -- | $-0.12 |
| 2020-11-16 | 2020-09-30 | $-0.60 | $-0.60 |
| 2020-08-06 | 2020-06-30 | $-0.48 | $-0.84 |
| 2020-05-14 | 2020-03-31 | -- | $-0.60 |
| 2020-03-27 | 2019-12-31 | -- | $-0.60 |
| 2019-11-12 | 2019-09-30 | -- | $-0.72 |
| 2019-08-09 | 2019-06-30 | -- | $-0.60 |
| 2019-05-10 | 2019-03-31 | -- | $1.20 |
| 2018-11-12 | 2018-09-30 | -- | $-0.72 |
| 2018-08-09 | 2018-06-30 | -- | $-0.60 |
| 2018-05-11 | 2018-03-31 | -- | $-0.72 |
| 2018-03-22 | 2017-12-31 | -- | $2.40 |